Key statistics
As of last trade, Biontech SE (22UA:GER) traded at 86.55, 18.32% above the 52 week low of 73.15 set on Apr 07, 2025.
52-week range
| Open | 86.50 |
|---|---|
| High | 87.10 |
| Low | 86.50 |
| Bid | 86.60 |
| Offer | 86.90 |
| Previous close | 85.95 |
| Average volume | 44.06k |
|---|---|
| Shares outstanding | 259.03m |
| Free float | 233.52m |
| P/E (TTM) | -- |
| Market cap | 26.10bn USD |
| EPS (TTM) | -2.74 USD |
Data delayed at least 15 minutes, as of Mar 04 2026 08:08 GMT.
More ▼
- EQS-News: BIO-Europe Spring® 2026 Charts the Future of Life Sciences from Lisbon’s Shores
- BioNTech veröffentlicht am 10. März 2026 Ergebnisse für das vierte Quartal und das Geschäftsjahr 2025 und informiert über operativen Fortschritt
- BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026
- BioNTech ernennt Kylie Jimenez zur neuen Personalvorständin
- BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer
- J.P. Morgan Healthcare Conference: signals for a re-rating of the sector are gaining momentum
- BioNTech präsentiert auf der 44. J.P. Morgan Healthcare-Konferenz Updates zur Geschäftsentwicklung und Schwerpunkte für das Jahr 2026
- BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference
- BioNTech schließt Übernahme von CureVac N.V. samt damit verbundener Nachangebotsfrist ab und stärkt so die einzigartige Position im mRNA-Feld
- BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
More ▼
